PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
Trial details
- Registry ID
- NCT04142658
- Drugs studied
- Apixaban 2.5 MG, Apixaban 5 MG, On-X Aortic Mechanical Valve, Warfarin
TrialRedline tracks 1 clinical trial sponsored by Artivion Inc.: 1 Phase 3.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanNCT04142658 | Apixaban 2.5 MG, Apixaban 5 MG, On-X Aortic Mechanical Valve, Warfarin | Terminated | 2022-12-12Actual |
Names as written in the registry records.